🔗 Share this article

An underground economy for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to recent findings.

Experimental Drug Acquiring Traction Online

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged fat-burning properties. Viewers are encouraged to contact these accounts directly for supplier links, while also receiving promotional offers.

Active Commerce on Social Networks

Additionally, a robust trade exists on Telegram, where groups with numerous of participants share “before and after” photos, administration instructions and assertions of next-day British shipping. Vendors promote the substance there before directing customers to other platforms for transactions.

Understanding Retatrutide

This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Medical Professionals Voice Worries

However, doctors and pharmacists have cautions that the sale of what remains an unapproved drug in the United Kingdom is a cause for concern and could result in users administering products of unknown origin.

Some experts said the popularity for the experimental drug could be linked to the rising price of approved slimming products such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that must not be marketed or supplied for human use under the British medical regulations.

Several influencers try to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still violate medicines, marketing, and consumer laws, risking penalties, legal action or imprisonment.

Service Reaction and Content Elimination

According to the social media company, the service has taken down problematic content and banned related keywords and query recommendations. The company stated it was dedicated to maintaining the platform safe and allocating resources in strengthening enforcement strategies.

Online Marketplace Operations

Investigations also found groups with up to nine thousand participants marketing the experimental drug using Telegram's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” instantly displays channels with thousands of users, filled with photos of slimming results, positive testimonials and detailed instructions for mixing or administering at home.

Within minutes of entering one group, a vendor shared contact information, where most transactions occur. The seller provided an guidebook and guaranteed delivery within two days. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one asked about body mass, health issues or past usage.

Product Information and Pricing

Within these communities, messages show black plastic parcels with Royal Mail stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at residence with purified liquid, or pre-filled pens usually sold at £160 for 20mg. When questioned how much time a injector should be used, vendors give conflicting responses varying between a several days to “depends on your body”.

Platform Oversight and Security Measures

A spokesperson for the messaging service stated it regularly monitored harmful content on its service including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering materials they cannot confirm. Although the research behind this drug is valid, these digital versions may not contain what they advertise,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the increase in interest to recent price rises for authorized slimming drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s inside or whether the conditions they were made in was sterile,” she said.

Her team has previously seen patients harmed by personal administration from unconfirmed sources. “We recognize the frustration, but buying from Telegram or communication platforms is taking chances with your health,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”

Producer Position

A representative from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Consequently at this point no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a company investigational substance not yet authorized … may expose patients to potentially serious medical dangers”.